PMID- 31755571
OWN - NLM
STAT- MEDLINE
DCOM- 20210112
LR  - 20210112
IS  - 1525-1470 (Electronic)
IS  - 0736-8046 (Linking)
VI  - 37
IP  - 1
DP  - 2020 Jan
TI  - Pediatric Kaposi's sarcoma associated with immune reconstitution inflammatory 
      syndrome.
PG  - 239-240
LID - 10.1111/pde.14056 [doi]
AB  - Immune reconstitution inflammatory syndrome (IRIS) represents paradoxical 
      immune-mediated inflammation in response to an infecting pathogen, occurring 
      after initiation of antiretroviral therapy (ART), concomitantly with immune 
      system recovery. It has also been described in Kaposi's sarcoma (KS). We report a 
      case of a 9-year-old Guinean girl, who developed Kaposi's sarcoma, following 
      introduction of ART. KS associated with immune reconstitution inflammatory 
      syndrome is rare, especially in children, but with the increased use of ART is 
      becoming more prevalent.
CI  - (c) 2019 Wiley Periodicals, Inc.
FAU - Silva, Leandro
AU  - Silva L
AUID- ORCID: 0000-0001-7804-3092
AD  - Department of Dermatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa 
      Ocidental, EPE, Lisboa, Portugal.
FAU - Azurara, Laura
AU  - Azurara L
AD  - Department of Pediatrics, Hospital de Sao Francisco Xavier, Centro Hospitalar de 
      Lisboa Ocidental, EPE, Lisboa, Portugal.
FAU - Monteiro, Ana Filipe
AU  - Monteiro AF
AD  - Department of Dermatology, Hospital Distrital de Santarem, EPE, Lisboa, Portugal.
FAU - Miroux-Catarino, Alexandre
AU  - Miroux-Catarino A
AUID- ORCID: 0000-0001-8243-8724
AD  - Department of Dermatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa 
      Ocidental, EPE, Lisboa, Portugal.
FAU - Amaro, Cristina
AU  - Amaro C
AD  - Department of Dermatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa 
      Ocidental, EPE, Lisboa, Portugal.
FAU - Viana, Isabel
AU  - Viana I
AD  - Department of Dermatology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa 
      Ocidental, EPE, Lisboa, Portugal.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20191122
PL  - United States
TA  - Pediatr Dermatol
JT  - Pediatric dermatology
JID - 8406799
RN  - 0 (Anti-HIV Agents)
RN  - 0 (Dideoxynucleosides)
RN  - 2494G1JF75 (Lopinavir)
RN  - 2T8Q726O95 (Lamivudine)
RN  - O3J8G9O825 (Ritonavir)
RN  - WR2TIP26VS (abacavir)
SB  - IM
MH  - Acquired Immunodeficiency Syndrome/complications/*drug therapy
MH  - Anti-HIV Agents/*adverse effects/*therapeutic use
MH  - Antiretroviral Therapy, Highly Active/*adverse effects
MH  - Child
MH  - Dideoxynucleosides/administration & dosage/adverse effects
MH  - Drug Therapy, Combination
MH  - Female
MH  - Humans
MH  - Immune Reconstitution Inflammatory Syndrome/*chemically induced/etiology
MH  - Lamivudine/administration & dosage/adverse effects
MH  - Lopinavir/administration & dosage/adverse effects
MH  - Ritonavir/administration & dosage/adverse effects
MH  - Sarcoma, Kaposi/*drug therapy/etiology/pathology
OTO - NOTNLM
OT  - Kaposi's sarcoma
OT  - immune reconstitution inflammatory syndrome
EDAT- 2019/11/23 06:00
MHDA- 2021/01/13 06:00
CRDT- 2019/11/23 06:00
PHST- 2019/11/23 06:00 [pubmed]
PHST- 2021/01/13 06:00 [medline]
PHST- 2019/11/23 06:00 [entrez]
AID - 10.1111/pde.14056 [doi]
PST - ppublish
SO  - Pediatr Dermatol. 2020 Jan;37(1):239-240. doi: 10.1111/pde.14056. Epub 2019 Nov 
      22.